AAPM Banner
  • Volume/Page
  • Keyword
  • DOI
  • Citation
  • Advanced
   
 
 
 
Medical Physics / Volume 38 / Issue 12 / POINT/COUNTERPOINT

Med. Phys. 38, 6347 (2011); http://dx.doi.org/10.1118/1.3639137 (4 pages)

Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process

David J. Carlson, Ph.D.

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040 (Tel: 203-200-2018; E-mail: david.j.carlson@yale.edu)

Kamil M. Yenice, Ph.D.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637 (Tel: 773-702-6876; E-mail: kyenice@radonc.uchicago.edu)

Colin G. Orton, Ph.D., Moderator
View MapView Map

(Received 7 July 2011; accepted 7 July 2011; published online 9 November 2011)

Full Text: Read Online (HTML) | Download PDF FREE | View Cart
Abstract unavailable.

ACKNOWLEDGMENTS

Dr. Carlson would like to thank Dr. J. Martin Brown (Stanford), Dr. Zhe J. Chen (Yale), Dr. Roy H. Decker (Yale), Dr. Malte C. Frese (DKFZ), Dr. Edward E. Graves (Stanford), and Dr. Robert D. Stewart (U of Washington) for many valuable conversations on this subject.

Article Outline

  1. OVERVIEW
  2. FOR THE PROPOSITION: David J. Carlson, Ph.D.
    1. Opening Statement
  3. AGAINST THE PROPOSITION: Kamil M. Yenice, Ph.D.
    1. Opening Statement
    2. Rebuttal: David J. Carlson, Ph.D.
    3. Rebuttal: Kamil M. Yenice, Ph.D.
Digital Object Identifier
http://dx.doi.org/10.1118/1.3639137

KEYWORDS and PACS

Keywords

biological tissues, cellular biophysics, dosimetry, radiation therapy, tumours

PACS

  • 87.53.Jw

    Therapeutic applications, including brachytherapy

  • 87.17.-d

    Cell processes

  • 87.53.Bn

    Dosimetry/exposure assessment

PUBLICATION DATA

ISSN

0094-2405 (print)  

Publisher

$abstract.society.value is a Member of CrossRef American Association of Physicists in Medicine

  1. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, “Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck,” Int. J. Radiat. Oncol., Biol., Phys. 38, 285–289 (1997). [ISI] [MEDLINE]
  2. P. Vaupel and M. Hockel, in Tumor Oxygenation, edited by P. Vaupel, D. Kelleher, and M. Gunderoth (Gustav Fischer Verlag, Stuttgart, Germany, 1995), pp. 219–232.
  3. J. M. Brown. “Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies,” Mol. Med. Today 6, 157–162 (2000).
  4. E. K. Rofstad, K. Sundfor, H. Lyng, and C. G. Trope, “Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis,” Brit. J. Canc. 83, 354–359 (2000). [MEDLINE]
  5. J. M. Brown, M. Diehn, and B. W. Loo, Jr., “Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer,” Int. J. Radiat. Oncol., Biol., Phys. 78, 323–327 (2010).
  6. D. J. Carlson, P. J. Keall, B. W. Loo, Jr., Z. J. Chen, and J. M. Brown, “Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia,” Int. J. Radiat. Oncol., Biol., Phys. 79, 1188–1195 (2011).
  7. S. M. Bentzen and V. Gregoire, “Molecular imaging-based dose painting: A novel paradigm for radiation therapy prescription,” Semin. Radiat. Oncol. 21, 101–110 (2011).
  8. Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, “The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography,” Int. J. Radiat. Oncol., Biol., Phys. 70, 1219–1228 (2008). [Inspec] [MEDLINE]
  9. S. Benedict, K. Yenice, D. Followill, J. Galvin, W. Hinson, B. Kavanagh, P. Keall, M. Lovelock, S. Meeks, L. Papiez, T. Purdie, R. Sadagopan, M. Schell, B. Salter, D. Schlesinger, A. Shiu, T. Solberg, D. Song, V. Stieber, R. Timmerman, W. Tome, D. Verellen, L. Wang, and F. Yin, “Stereotactic body radiation therapy: The report of AAPM Task Group No. 101,” Med. Phys. 37, 4078–4101 (2010)MPHYA6000037000008004078000001. [MEDLINE]
  10. I. S. Grills, V. S. Mangona, R. Welsh, G. Chmielewski, E. McInerney, S. Martin, J. Wloch, H. Ye, and L. L. Kestin. “Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer,” J. Clin. Oncol. 28, 928–935 (2010). [MEDLINE]
  11. R. D. Timmerman, C. S. Bizekis, H. I. Pass, Y. Fong, D. E. Dupuy, L. A. Dawson, and D. Lu. “Local surgical, ablative, and radiation treatment of metastases,” Ca-Cancer J. Clin. 59, 145–170 (2009). [MEDLINE]
  12. R. Ruggieri, S. Naccarato, and A. E. Nahum. “Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia,” Acta Oncol. 49, 1304–1314 (2010).
  13. A. R. Padhani, K. A. Krohn, J. S. Lewis, and M. Alber, “Imaging oxygenation of human tumours,” Eur. Radiol. 17, 861–872 (2007). [MEDLINE]
  14. S. A. Nehmeh et al., “Reproducibility of intratumor distribution of 18F-fluoromisonidazole in head and neck cancer,” Int. J. Radiat. Oncol., Biol., Phys. 70, 235–242 (2008). [Inspec] [MEDLINE]
  15. C. C. Ling et al., “Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality,” Int. J. Radiat. Oncol., Biol., Phys. 47, 551–560 (2000). [MEDLINE]
  16. I. Toma-Daşu, J. Uhrdin, A. Daşu, and A. Brahme, “Therapy optimization based on non-linear uptake of PET tracers versus linear dose painting,” IFMBE Proc. 25, 221–224 (2009).
  17. Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, “The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography,” Int. J. Radiat. Oncol., Biol., Phys. 70, 1219–1228 (2008). [Inspec] [MEDLINE]
  18. D. Thorwarth, S. M. Eschmann, F. Paulsen, and M. Alber, “Hypoxia dose painting by numbers: A planning study,” Int. J. Radiat. Oncol., Biol., Phys. 68, 291–300 (2007). [Inspec] [MEDLINE]
  19. J. F. Fowler, “The linear-quadratic formula and progress in fractionated radiotherapy,” Brit. J. Radiol. 62, 679–694 (1989). [Inspec] [ISI] [MEDLINE]
  20. J. P. Kirkpatrick, J. J. Meyer, and L. B. Marks, “The Linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery,” Sem. Radiat. Oncol. 18, 240–243 (2008). [MEDLINE]
  21. M. Kocher et al., “Adjuvant whole brain radiotherapy vs observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study,” Int. J. Radiat. Oncol., Biol., Phys. 75, S5, Abstract (2009).
  22. J. Overgard and M. R. Horsman, “Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers,” Sem. Radiat. Oncol. 6, 10–21 (1996).


Close

Medical Physics is an official science journal of the AAPM and of the COMP/CCPM/IOMP
William R. Hendee, Editor
Departments of Radiology, Radiation Oncology, Biophysics, Community and Public Health, Medical College of Wisconsin
One Physics Ellipse
College Park, Maryland 20740
301-209-3352

© 2012, American Association of Physicists in Medicine. Individual readers of this journal, and nonprofit libraries acting for them, are freely permited to make fair use of the material in it, such as to copy an article for use in teaching or research. (For other kinds of copying see "Copying Fees.") Permission is granted to quote from this journal in scientific works with the customary acknowledgment of the source. To reprint a figure, table, or other excerpt requires, in addition, AAPM may require that permission also be obtained from one of the authors. Address inquiries and notices to Penny Slattery, Journal Manager, Medical Physics Journal, AAPM, One Physics Ellipse, College Park, MD 20740-3846; email: journal@aapm.org.

close